Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/18/22
End: 09/18/23
Due: 09/18/24
Phase: N/A
Priority: Normal
Start: 06/15/23
End: 12/31/26
Due: 12/31/27
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Effect and Safety of Envafolimab Combined With Endostar/S-1 in Second-line of Advanced Non-small Cell Lung Cancer | NCT05529355 | Anhui Chest Hospital | user2@example.com | None | 2022-09-18 | 2023-09-18 | 2024-09-18 | - | - | 2025-07-14 |
| Oral Metronomic Vinorelbine and PD-1 Inhibitors in Elderly Non-small Cell Lung Cancer | NCT07041320 | Anhui Chest Hospital | user2@example.com | None | 2023-06-15 | 2026-12-31 | 2027-12-31 | - | - | 2025-07-14 |